| 2-R01-EB025840-05 |
Deuterium metabolic imaging (DMI) of neurological disease |
Robin De Graaf |
Yale University |
| 5-R01-EB034978-02 |
Development and Translation of D-glucose as a Diagnostic Agent for MRI of Cancer |
Peter Van Zijl |
Hugo W. Moser Res Inst Kennedy Krieger |
| 5-U01-EB026412-05 |
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods |
Daniel Vigneron |
University of California, San Francisco |
| 5-R01-EB029985-04 |
Development of Enabling Technologies for Clinical Ultrahigh Field Body MRI |
Gregory Metzger |
University of Minnesota |
| 1-R21-EB032514-01A1 |
Development of Layer Specific FMRI for Clinical Scanners |
Luis Hernandez-Garcia |
University of Michigan at Ann Arbor |
| 1-R01-EB036368-01A1 |
Development of Susceptibility Weighted MRI for the Human Spinal Cord |
Seth Smith |
Vanderbilt University Medical Center |
| 5-U01-EB029826-04 |
Development of the Human Dynamic Neurochemical Connectome Scanner |
Ciprian Catana |
Massachusetts General Hospital |
| 1-R01-EB030497-01 |
Diffusion MRI of the Abdomen |
Diego Hernando |
University of Wisconsin-Madison |
| 7-R01-EB030414-04 |
Discovery and Applied Research for Technological Innovations to ImproveHuman Health |
William Grissom |
Case Western Reserve University |
| 5-R03-EB034480-02 |
Distortion Correction in Functional MRI with Deep Learning |
Qingfei Luo |
University of Illinois at Chicago |
